OHSU in the news

Oregon lawmakers hear testimony on abortion gender affirming care

Oregon Capital Chronicle March 21, 2023
House Bill 2002 would expand insurance coverage for medically necessary gender-affirming care. Christina Milano, M.D., medical director of the OHSU Transgender Health Program, says that ensuring transgender Oregonians are able to access health care in a safe environment can impact their overall health.

Kotek targets behavioral health system crisis – and plans ahead

The Lund Report March 21, 2023
The Lund Report published a story citing testimony from Beech Burns, M.D., describing how the lack of services in rural communities impacts families with children struggling with thoughts of self-harm: If doctors decide the child doesn’t need to be hospitalized “they are discharged the same day back to their community, with the family left to determine how to arrange transportation home and how they will pay for the ambulance fee and cost of the emergency department visit.

Oregon governor's $80M behavioral health plan

Becker's Behavioral Health March 21, 2023
Becker's Hospital Review reports on the governor's $80 million budget for behavioral health, including $1.5 million to OHSU to coordinate the availability of behavioral health residential beds statewide.

OSU: DEAN NAMED FOR COLLEGE OF PHARMACY

The Corvallis Advocate March 20, 2023
David Bearden is named dean of the OSU College of Pharamacy and is credited with enhancing "OSU’s College of Pharmacy’s connections with Oregon Health & Science University’s academic and clinical pharmacy units," which include a jointly-conferred doctorate of pharmacy degree program from OSU and OHSU, and OSU pharmacy’s programs offered at the Robertson Collaborative Life Sciences Building in Portland.

Dupilumab improves hand, foot atopic dermatitis in phase 3 study

Healio Dermatology March 19, 2023
During a presentation at the American Academy of Dermatology Annual Meeting, Eric Simpson, M.D., M.C.R., reports results from a phase III study that found the monoclonal antibody dupilumab improved symptoms for trial participants with hand and foot atopic dermatitis, also known as eczema. Simpson says: “We are pleased to see such strong results in patients that experience intense itch and painful skin lesions on such critical areas of the body."

Genetic Testing and Melanoma

Managed Healthcare Executive March 19, 2023
Sancy Leachman, M.D., Ph.D., says germline testing might be warranted after a patient has had three melanomas or has a family history of three first- and second-degree relatives having melanoma.

OHSU medical students find out where they will go for their residency during 'Match Day'

KATU-TV March 18, 2023
Alexandra Levin, M.P.H., was among the 165 fourth-year OHSU M.D. students who matched with residency programs on March 17. Levin, who was matched with the joint OHSU-Sky Lakes Cascades East Family Medicine Residency Program in Klamath Falls, says: “I’m thrilled to be going to a program that fits me so well and will train me to be a true, full-spectrum rural family physician. I’m feeling elation, joy, and excitement.”

In rural Oregon, there’s a higher need for mental health care, but few options

Oregon Public Broadcasting March 17, 2023
An OPB story discusses the alarming rates of depression, anxiety and suicidality, as well as increased demand for mental health care, in Oregon’s rural and coastal communities. Ajit Jetmalani, M.D., says: “People feel like things are completely chaotic and there’s no plan, but there really is a plan.”
See more stories